Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA. (Q44357517)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 August 2002

Language	Label	Description	Also known as
English	Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA.	scientific article published on 9 August 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

morphine dependence

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Piotr Popik

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Malgorzata Holuj

object named as

Malgorzata Wróbel

3

0 references

author name string

Ewa Kozela

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Krystyna M Wozniak

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Barbara S Slusher

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

9 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

457-467

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300048

0 references

Single-trial conditioned place preference using intravenous morphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Place conditioning with morphine and phencyclidine: dose dependent effects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Pharmacology and functions of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Genetic differences in the rewarding and activating effects of morphine and ethanol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Differential binding of [3H]MK-801 to brain regions and spinal cord of mice treated chronically with morphine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Reinforcements from the first drug experience can predict later drug habits and/or addiction: Results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, heroin, opiates and cocaine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Oxiracetam prevents the MK-801 induced amnesia for the elevated plus-maze in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Design of NAALADase inhibitors: a novel neuroprotective strategy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Drug addiction, dysregulation of reward, and allostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Chronic opiate receptor activation in vivo alters the level of G-protein subunits in guinea-pig myenteric plexus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Blockade of morphine-induced analgesia and tolerance in mice by MK-801.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

NAALADase inhibition reduces alcohol consumption in the alcohol-preferring (P) line of rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: a procedural examination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Drug reinforcement studied by the use of place conditioning in rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

N-acetylaspartylglutamate acts as an agonist upon homomeric NMDA receptor (NMDAR1) expressed in Xenopus oocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Tolerance and selective cross-tolerance to the motivational effects of opioids.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Modulation of behavioral sensitization to cocaine by NAALADase inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-alpha-linked-acidic dipeptidase (NAALADASE).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Immunocytochemical distribution of N-acetylaspartylglutamate in the rat forebrain and glutamatergic pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Selective release of N-acetylaspartylglutamate from rat optic nerve terminals in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Ultrastructural localization of N-acetylaspartylglutamate in synaptic vesicles of retinal neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

N-acetylaspartylglutamate inhibits forskolin-stimulated cyclic AMP levels via a metabotropic glutamate receptor in cultured cerebellar granule cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Spinal N-acetyl-alpha-linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Inhibition of spinal N-acetylated-alpha-linked acidic dipeptidase produces an antinociceptive effect in the rat formalin test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

NMDA-R1 antisense oligonucleotide attenuates withdrawal signs from morphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

21 January 2018

Dissociation of tolerance and dependence for opioid peripheral antinociception in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-acting NMDA receptor antagonist MRZ 2/576 produces prolonged suppression of morphine withdrawal in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

N-acetylaspartylglutamate selectively inhibits neuronal responses to N-methyl-D-aspartic acid in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

NMDA-dependent modulation of CA1 local circuit inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

N-acetyl-aspartyl-glutamate (NAAG) elicits rapid increase in intraneuronal Ca2+ in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphine dependence with or without tolerance in formalin-treated mice: further evidence for the dissociation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of N-acetylated alpha-linked acidic dipeptidase (NAALADase) inhibitors on [3H]NAAG catabolism in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300048

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300048

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44357517&oldid=1656735992"